Jianhui Wu Selected Research

carthamine

1/2022

Both Two CtACO3 Transcripts Promoting the Accumulation of the Flavonoid Profiles in Overexpressed Transgenic Safflower.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianhui Wu Research Topics

Disease

45	Neoplasms (Cancer) 02/2022 - 10/2009
17	Thrombosis (Thrombus) 01/2020 - 01/2011
12	Inflammation (Inflammations) 01/2020 - 03/2010
7	Carcinogenesis 04/2022 - 01/2014
7	Edema (Dropsy) 01/2020 - 03/2010
7	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2014
5	Infections 06/2022 - 07/2015
5	Nasopharyngeal Carcinoma 12/2020 - 03/2010
5	Carcinoma (Carcinomatosis) 07/2018 - 03/2010
4	Hyperplasia 10/2021 - 09/2017
4	Retroperitoneal liposarcoma 01/2021 - 10/2019
4	Prostatic Neoplasms (Prostate Cancer) 02/2020 - 03/2010
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 10/2017
3	Body Weight (Weight, Body) 12/2021 - 01/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2020
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2014
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 04/2022 - 01/2020
2	Abscess 03/2022 - 05/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2021
2	Hypoxia (Hypoxemia) 05/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
2	Liposarcoma 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2021 - 09/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2019 - 05/2019
2	Breast Neoplasms (Breast Cancer) 12/2018 - 03/2010
2	Hemorrhage 01/2018 - 12/2011
2	Chronic Pain 09/2011 - 03/2010
1	Vascular Diseases (Vascular Disease) 01/2022
1	Leukoplakia 10/2021
1	Brain Injuries (Brain Injury) 08/2021
1	Osteosarcoma (Osteogenic Sarcoma) 06/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2021
1	Dyspnea (Shortness of Breath) 05/2021
1	Brain Hypoxia (Cerebral Hypoxia) 05/2021

Drug/Important Bio-Agent (IBA)

11	AcidsIBA 01/2019 - 10/2009
10	P-SelectinIBA 01/2020 - 10/2012
8	Long Noncoding RNAIBA 06/2021 - 07/2017
8	Interleukin-8 (Interleukin 8)IBA 01/2020 - 03/2015
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2018
6	Xylenes (Xylene)IBA 01/2020 - 03/2010
6	Biological ProductsIBA 01/2020 - 12/2011
5	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2014
5	bisphenol AIBA 04/2022 - 09/2017
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2010
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
5	Amino Acids FDA Link 01/2015 - 03/2010
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 09/2013
4	Adenosine Diphosphate (ADP)IBA 10/2017 - 01/2011
3	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2021
3	AlbuminsIBA 05/2021 - 09/2020
3	PlatinumIBA 01/2021 - 12/2011
3	Estrogens (Estrogen)FDA Link 10/2019 - 01/2017
3	Intercalating AgentsIBA 01/2019 - 09/2010
3	Testosterone (Sustanon)FDA Link 08/2018 - 01/2017
3	imidazo(1,2-a)quinoxaline-2-carboxylic acidIBA 01/2018 - 02/2017
3	Carbolines (Beta-Carbolines)IBA 01/2017 - 09/2010
3	Analgesics (Analgesic Drugs)IBA 01/2015 - 03/2010
3	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2011 - 10/2009
2	5-dimethylaminonaphthalene-1-sulfonamideIBA 03/2022 - 05/2021
2	Endocrine DisruptorsIBA 10/2021 - 09/2017
2	Untranslated RNA (Noncoding RNA)IBA 06/2021 - 12/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2017
2	CytokinesIBA 01/2021 - 01/2020
2	ApolipoproteinsIBA 09/2020 - 03/2020
2	GlucocorticoidsIBA 09/2020 - 01/2016
2	Carbon DioxideIBA 09/2020 - 07/2015
2	Apolipoproteins E (ApoE)IBA 09/2020 - 03/2020
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2020 - 10/2019
2	arginyl-glycyl-aspartyl-valineIBA 01/2020 - 09/2013
2	Gemcitabine FDA Link 01/2020 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2017
2	BerberineIBA 01/2020 - 01/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2016
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	dimethyl 2,2'- ((2,2'- (ethane- 1,1- diyl)bis(1H- indole- 3,2- diyl))diacetateIBA 08/2018 - 01/2018
2	Diethylhexyl Phthalate (DEHP)IBA 08/2018 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 01/2017
2	Platelet Activating FactorIBA 10/2017 - 01/2015
2	Arachidonic Acid (Vitamin F)IBA 10/2017 - 01/2015
2	PyransIBA 09/2017 - 01/2017
2	Carboxylic AcidsIBA 09/2017 - 01/2017
2	Nanoparticle Drug Delivery SystemIBA 02/2017 - 09/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015 - 03/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2012 - 12/2011
2	EstersIBA 08/2011 - 03/2010
1	MycotoxinsIBA 06/2022
1	LigandsIBA 02/2022
1	carthamineIBA 01/2022
1	FlavonoidsIBA 01/2022
1	hydroxysafflor yellow AIBA 01/2022
1	A1443 compoundIBA 12/2021

Therapy/Procedure

9	Therapeutics 01/2021 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
2	Immunotherapy 02/2022 - 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 02/2022
1	Laryngoscopes 10/2021
1	Critical Care (Surgical Intensive Care) 08/2021